DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
11.88
+0.37 (3.21%)
Nov 11, 2026, 4:00 PM EST - Market closed
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $743.94 million as of November 11, 2026. Its market cap has increased by 61.97% in one year.
Market Cap
743.94M
Enterprise Value
589.37M
1-Year Change
61.97%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since October 22, 2014, DBV Technologies's market cap has decreased from $844.80M to $743.94M, a decrease of -11.94%. That is a compound annual growth rate of -1.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 747.00M | 15.21% |
| Dec 31, 2025 | 648.40M | 987.92% |
| Dec 31, 2024 | 59.60M | -67.52% |
| Dec 29, 2023 | 183.50M | -36.22% |
| Dec 30, 2022 | 287.70M | 63.47% |
| Dec 31, 2021 | 176.00M | -28.57% |
| Dec 31, 2020 | 246.40M | -68.16% |
| Dec 31, 2019 | 773.80M | 141.13% |
| Dec 31, 2018 | 320.90M | -73.54% |
| Dec 29, 2017 | 1.21B | -28.69% |
| Dec 30, 2016 | 1.70B | 22.23% |
| Dec 31, 2015 | 1.39B | 39.07% |
| Dec 31, 2014 | 1.00B | 18.43% |
| Oct 22, 2014 | 844.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prime Medicine | 764.99M |
| Attovia Therapeutics | 763.75M |
| Janux Therapeutics | 758.06M |
| OmniAb | 743.89M |
| Cullinan Therapeutics | 736.85M |
| Iambic Therapeutics | 729.26M |
| Nuvectis Pharma | 722.17M |
| Climb Bio | 719.54M |